These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
4. The future of the artificial kidney: moving towards wearable and miniaturized devices. Ronco C, Davenport A, Gura V. Nefrologia; 2011 Nov; 31(1):9-16. PubMed ID: 21270908 [Abstract] [Full Text] [Related]
5. Haemodialysis with on-line monitoring equipment: tools or toys? Locatelli F, Buoncristiani U, Canaud B, Köhler H, Petitclerc T, Zucchelli P. Nephrol Dial Transplant; 2005 Jan; 20(1):22-33. PubMed ID: 15632348 [Abstract] [Full Text] [Related]
6. Challenges and future of renal replacement therapy. de Francisco AL, Piñera C. Hemodial Int; 2006 Jan; 10 Suppl 1():S19-23. PubMed ID: 16441862 [Abstract] [Full Text] [Related]
7. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids. Arogundade FA, Ishola DA, Sanusi AA, Akinsola A. Afr J Med Med Sci; 2005 Sep; 34(3):227-33. PubMed ID: 16749353 [Abstract] [Full Text] [Related]
8. Development of continuous implantable renal replacement: past and future. Fissell WH, Fleischman AJ, Humes HD, Roy S. Transl Res; 2007 Dec; 150(6):327-36. PubMed ID: 18022594 [Abstract] [Full Text] [Related]
10. Uremic toxins: a new focus on an old subject. Yavuz A, Tetta C, Ersoy FF, D'intini V, Ratanarat R, De Cal M, Bonello M, Bordoni V, Salvatori G, Andrikos E, Yakupoglu G, Levin NW, Ronco C. Semin Dial; 2005 Dec; 18(3):203-11. PubMed ID: 15934967 [Abstract] [Full Text] [Related]